EUVIMEDEUVIMED entdecken
Crossref

Complications, implant survival and functional outcome of patients with pelvic metastasis treated with standard or dual mobility bearing total hip arthroplasty and antiprotrusio cage

Ariya Panutut, Konstantina Solou, Monica Cosentino, Federica Zuccheri, Ahmed Atherley O'Meally, Cesar Chacon, Federico Tubertini, Ayano Aso, Sittichoke Watcharamasbonkkot, Barbara Dozza, Barbara Bordini, Davide Maria Donati und 1 weitere

International Orthopaedics · 2026

DOI: 10.1007/s00264-025-06697-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Orthopaedics, 2026. Verfasst von Ariya Panutut und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinica Ortopedica e Traumatologica III a Prevalente Indirizzo Oncologico, Musculoskeletal Oncology Department, IRCCS Istituto Ortopedico Rizzoli, Is…. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Hip Prosthesis, Bone Neoplasms, Pelvic Bones. Die Arbeit nennt 22 Literaturangaben. Gefördert von: NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The goal of surgery for pelvic metastasis is pain-free reconstruction that enables daily activity without complications for the patient's remaining life. The purpose of our study was to assess complications, reoperations, functional outcomes, and survival in patients with pelvic metastasis treated with standard or dual mobility total hip arthroplasty (THA) and antiprotrusio cage. METHODS: We prospectively analyzed 36 patients with pelvic metastasis who underwent reconstruction with standard (n = 20) or dual mobility (n = 16) bearing THA and antiprotrusio cage between 2015 and 2024 at a single institution. We evaluated complications, reoperations, functional outcomes and survival. RESULTS: Infection occurred in five of 36 patients (14%): three patients required surgical debridement and two were managed with antibiotics. No dislocations were observed in both standard and dual mobility bearing groups. Local disease progression developed in seven of 36 patients (19%), with only one patient requiring acetabular revision at 63 months postoperatively. Survival of implant was 85.8% (95% CI 74.9%-98.2%) at one year after reconstruction. Median MSTS scores were 22.5 and 20.0 in the standard and dual mobility bearing groups, respectively (p = 0.564), with no difference in ambulation status. Patient survival was 77.7% (95% CI 65.2%-92.6%) at one year and 12.8% (95% CI 4.5%-36.1%) at five years. CONCLUSION: Patients with pelvic metastasis treated with standard or dual mobility bearing THA with antiprotrusio cage may effectively restore painless function. Despite high risk of infection and local disease progression, no dislocation occurred, supporting this reconstruction as an acceptable surgical option for patients with pelvis metastasis who need surgical treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthroplasty, Replacement, HipHip ProsthesisBone NeoplasmsPelvic BonesPelvic NeoplasmsHumansMaleFemaleAgedMiddle AgedProspective StudiesReoperationTreatment OutcomePostoperative ComplicationsProsthesis FailureProsthesis DesignAdultAged, 80 and over

Stichwörter der Autor:innen

Antiprotrusio cageComplicationDual mobility total hip arthroplastyImplant survivalPelvic metastasisStandard total hip arthroplasty

Autor:innen und Institutionen

  • Clinica Ortopedica e Traumatologica III a Prevalente Indirizzo Oncologico, Musculoskeletal Oncology Department, IRCCS Istituto Ortopedico Rizzoli, Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Department of Orthopaedics, Phramongkutklao Hospital, Bangkok, Thailand.
  • Department of Orthropaedic Surgery, Tzaneion General Hospital, Piraeus, Greece.
  • Medical Technology Laboratory, Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Department of Orthopaedic Surgery, Complejo Hospitalario Metropolitano CSS, Panama, Panama.
  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Förderung

  • NextGenerationEU

Zitieren

APA

Panutut, A., Solou, K., Cosentino, M., Zuccheri, F., O'Meally, A. A., Chacon, C., Tubertini, F., Aso, A., Watcharamasbonkkot, S., Dozza, B., Bordini, B., Donati, D. M., & Errani, C. (2026). Complications, implant survival and functional outcome of patients with pelvic metastasis treated with standard or dual mobility bearing total hip arthroplasty and antiprotrusio cage. International Orthopaedics. https://doi.org/10.1007/s00264-025-06697-9

Vancouver

Panutut A, Solou K, Cosentino M, Zuccheri F, O'Meally AA, Chacon C, et al. Complications, implant survival and functional outcome of patients with pelvic metastasis treated with standard or dual mobility bearing total hip arthroplasty and antiprotrusio cage. International Orthopaedics. 2026. doi:10.1007/s00264-025-06697-9

BibTeX
@article{Panutut2026,
  author = {Panutut, Ariya and Solou, Konstantina and Cosentino, Monica and Zuccheri, Federica and O'Meally, Ahmed Atherley and Chacon, Cesar and Tubertini, Federico and Aso, Ayano and Watcharamasbonkkot, Sittichoke and Dozza, Barbara and Bordini, Barbara and Donati, Davide Maria and Errani, Costantino},
  title = {Complications, implant survival and functional outcome of patients with pelvic metastasis treated with standard or dual mobility bearing total hip arthroplasty and antiprotrusio cage},
  journal = {International Orthopaedics},
  year = {2026},
  doi = {10.1007/s00264-025-06697-9}
}
Kostenlos starten →